Autres langues Alkem Laboratories Limited

Actions

ALKEM

INE540L01014

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:07 14/05/2026			Varia. 5j.	Varia. 1 janv.
5 576,50 ^INR	+2,09 %		+0,35 %	+1,27 %

08/05	Alkem Labs : la FDA américaine mène une inspection inopinée sur un site de CRO	RE
05/05	Alkem Labs : une décision en appel annule une demande de redressement fiscal de 696,6 millions de roupies	RE

Autres langues

08/05	Alkem Labs says US FDA conducts unannounced inspection at Alkem CRO facility
05/05	Alkem Labs says Order-In-Appeal drops tax demand of 696.6 million rupees
04/05	Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection
24/04	Alkem Labs gets tax demand of 3.3 billion rupees
24/04	Alkem Laboratories Limited Announces Resignation of Vikas Gupta as Key Managerial Personnel, Effective June 30, 2026
24/04	Alkem Laboratories Limited Announces Resignation of Chief Executive Officer Vikas Gupta, Effective June 30, 2026
13/04	Alkem Pharma Trading FZCO announced that it has received AED 3.67 million in funding from Alkem Laboratories Limited
07/04	Alkem Laboratories Limited Launches A to Z Daily Multivitamin Supplement for Adults
02/04	Alkem Laboratories Gets Board Nod to Boost Investment in New Factory
02/04	Alkem Labs says board approves increase investment to up to 10.36 bln rupees from 5.33 bln rupees for Ujjain facility
30/03	Alkem Labs incorporates wholly owned subsidiary in Dubai Healthcare City, UAE
27/03	Alkem Laboratories Limited Appoints Samsher Kumar Deo to Senior Management Position, Effective March 27, 2026
23/03	Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
21/03	Alkem Laboratories Limited Launches Semaglutide Injection in India
21/03	Alkem Labs launches semaglutide injection in India with weekly therapy starting at 450 rupees
20/03	Alkem Laboratories Limited Receives EU GMP Certificate for Manufacturing Facility Located At Daman, India from Malta Medicines Authority
19/03	Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
18/03	Alkem Labs receives 30 acre land allotment in Ujjain for greenfield facility
14/03	Alkem Laboratories Limited Receives Certificate of GMP Compliance of a Manufacturer For Manufacturing Facility Located At Baddi, India from Department of Pharmacy (Human Medicines) ? Germany
06/03	Alkem Laboratories Unit to Acquire Majority Stake Switzeland-Based Occlutech
18/02	Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL and NEXLIZET Prior to April 19, 2040
16/02	Alkem Labs says US FDA issues Form 483 with 6 procedural observations
13/02	Deals of the day-Mergers and acquisitions
13/02	Alkem Laboratories' Consolidated Profit Rises in Fiscal Q3; Shares Down 8%
13/02	Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025